Results 311 to 320 of about 3,814,564 (336)

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Diseño, caracterización, producción y utilización de vectores virales y plasmídicos para terapia génica del cáncer

, 2001
Mariana Berenstein
openalex   +1 more source

On Gender-Specific FIT Cutoffs in the Swedish Colorectal Cancer Screening Program. [PDF]

United European Gastroenterol J
Brenner H, Ola I, Seum T.
europepmc   +1 more source

Pain at the end of life in patients with cancer: a population-based study on prevalence, relief, and the role of pain assessment. [PDF]

Support Care Cancer
Slotman E, Hedman C, Fransen HP, van der Linden YM, Raijmakers NJH, Lundström S.   +5 more
europepmc   +1 more source

Impact of coexisting diabetes on the development of cardiovascular disease and death in patients with cancer. [PDF]

PLoS One
Kuwabara Y, Morishima T, Kudo H, Shimadzu Kato M, Koyama S, Nakata K, Miyashiro I.   +6 more
europepmc   +1 more source